Home Ingredients L-Phenylalanine / DLPA
Mood & Mental HealthCognitiveStress & Anxiety

L-Phenylalanine / DLPA

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

L-Phenylalanine is an essential aromatic amino acid and the precursor to tyrosine, dopamine, norepinephrine, epinephrine, and melanin. Found in meat, fish, dairy, soy, nuts, seeds. Sold supplementally as L-phenylalanine, D-phenylalanine, or DL-phenylalanine (DLPA — racemic mixture). Used for depression, ADHD, chronic pain, vitiligo, and as a catecholamine precursor. CRITICAL CONTRAINDICATION: PHENYLKETONURIA (PKU) — must completely avoid phenylalanine.

Studied Dose L-phenylalanine: 500–1,500 mg/day for mood/cognitive support; DLPA: 375–2,250 mg/day for chronic pain; vitiligo: 50–100 mg/kg combined with UV therapy
Active Compound L-Phenylalanine, D-Phenylalanine, or DL-Phenylalanine (DLPA — racemic)

Benefits

Catecholamine Precursor (Mood Support)

L-Phenylalanine converts to L-tyrosine, then to L-DOPA, then to dopamine, norepinephrine, and epinephrine. Theoretical basis for mood and cognitive support — though clinical trials in depression have been mixed and small.

Supported by Trial 1, Trial 2

Chronic Pain (DLPA)

D-phenylalanine (in DLPA) inhibits enkephalinase — the enzyme that breaks down endogenous opioid peptides (enkephalins). Theoretical mechanism for chronic pain modulation. Clinical evidence remains limited; no large rigorous RCTs definitively support DLPA for chronic pain despite popular use.

Supported by Trial 1

Vitiligo Adjunct (with UV Therapy)

L-Phenylalanine + UVA or UVB therapy has been studied for vitiligo (pigment-loss skin condition). Modest repigmentation reported in some trials. Standard vitiligo care includes topical corticosteroids, calcineurin inhibitors, JAK inhibitors (ruxolitinib), and excimer laser.

Supported by Trial 2, Trial 1

ADHD Support (Limited Evidence)

Theoretical use as catecholamine precursor for ADHD. Small trials have been mixed. Standard ADHD pharmacotherapy (stimulants like methylphenidate, amphetamines) has vastly stronger evidence.

Supported by Trial 1, Trial 2

Appetite Modulation

Phenylalanine stimulates cholecystokinin (CCK) release — promoting satiety. Modest evidence; not established weight management therapy.

Supported by Trial 1, Trial 2

Mechanism of action

1

Catecholamine Synthesis Pathway

Phenylalanine → tyrosine (via phenylalanine hydroxylase + BH4 cofactor) → L-DOPA (via tyrosine hydroxylase) → dopamine → norepinephrine → epinephrine. Phenylalanine hydroxylase deficiency causes phenylketonuria (PKU).

2

Melanin Synthesis

Phenylalanine → tyrosine → L-DOPA → dopaquinone → melanin. Basis for vitiligo therapy theory.

3

Enkephalinase Inhibition (D-Phenylalanine)

D-phenylalanine (the unnatural isomer) inhibits enkephalinase — the enzyme that degrades endogenous enkephalins (opioid peptides). Theoretical analgesic mechanism. L-phenylalanine does NOT have this effect.

4

CCK Release

Phenylalanine in the small intestine stimulates CCK release from I cells — promoting satiety and gallbladder contraction.

Clinical trials

1
DLPA for Depression — Older Pilot Studies
PubMed

Several small uncontrolled and pilot studies in 1970s-80s examining D-phenylalanine and DLPA for depression. (Beckmann et al. 1979 Arch Psychiatr Nervenkr; others)

Small depression pilots.

Modest signals reported, but trials were small, often uncontrolled, and used inconsistent methodology. CRITICAL CAVEAT: not replicated in modern rigorous RCTs. Standard depression care relies on SSRIs, SNRIs, atypical antidepressants, psychotherapy. DLPA remains alternative/CAM approach.

2
L-Phenylalanine + UVA for Vitiligo — Clinical Studies
PubMed

Several clinical studies examining oral L-phenylalanine + UVA exposure for vitiligo repigmentation. (Schulpis et al. 1989; Cormane et al. 1985; later studies)

Vitiligo patients.

Modest repigmentation reported in some trials, particularly with UVA exposure. Effect sizes variable. Standard vitiligo care has evolved — JAK inhibitors (topical ruxolitinib, FDA-approved 2022) represent significant advance.

Side effects and drug interactions

Common Potential side effects

Mild GI distress (nausea, heartburn) at higher doses.
Headache, anxiety, restlessness — particularly at high doses; reflects catecholamine elevation.
Insomnia if taken late in day — stimulating effect.
Increased blood pressure at high doses — caution with hypertension.

Important Drug interactions

MAOIs — DO NOT COMBINE; phenylalanine is precursor to catecholamines; MAOIs prevent their breakdown; HYPERTENSIVE CRISIS risk; CONTRAINDICATED.
L-DOPA / Sinemet — phenylalanine competes with L-DOPA for blood-brain barrier transport via large neutral amino acid transporter; can REDUCE L-DOPA efficacy in Parkinson's.
Antipsychotics — theoretical antagonism via dopaminergic effects.
Stimulants (methylphenidate, amphetamines) — additive catecholamine effects; potential for hypertension or anxiety.
SSRIs/SNRIs — generally compatible but theoretical serotonin/catecholamine interactions; monitor.
Selegiline (low-dose MAO-B selective) — caution; same MAOI concern at higher doses.

More Mood & Mental Health Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Men's Health
Folate
Folate, also known as vitamin B9, is a water-soluble vitamin commonly supplemented as foli…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…

Explore Other Ingredients

Antioxidant
Lutein
Lutein is a yellow carotenoid antioxidant that plays a key role in eye health, particularl…
Hair, Skin & Nails
Hyaluronic Acid
Hyaluronic acid is a naturally occurring substance in the body, primarily found in connect…
Immune Support
Vitamin C
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin commonly used in supple…

Frequently asked questions about L-Phenylalanine / DLPA

What is L-Phenylalanine / DLPA?

L-Phenylalanine is an essential aromatic amino acid and the precursor to tyrosine, dopamine, norepinephrine, epinephrine, and melanin.

What does L-Phenylalanine / DLPA do?

Phenylalanine → tyrosine (via phenylalanine hydroxylase + BH4 cofactor) → L-DOPA (via tyrosine hydroxylase) → dopamine → norepinephrine → epinephrine. Phenylalanine hydroxylase deficiency causes phenylketonuria (PKU). In clinical research, L-Phenylalanine / DLPA has been studied for catecholamine precursor (mood support), chronic pain (dlpa), vitiligo adjunct (with uv therapy).

Who should take L-Phenylalanine / DLPA?

L-Phenylalanine / DLPA may be most relevant for people interested in mood & mental health, cognitive, stress & anxiety. It has been clinically studied for catecholamine precursor (mood support), chronic pain (dlpa), vitiligo adjunct (with uv therapy). As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does L-Phenylalanine / DLPA take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take L-Phenylalanine / DLPA?

For stress and mood goals, L-Phenylalanine / DLPA can be taken in the morning, evening, or split through the day. Effects build gradually over weeks; daily consistency matters more than precise timing. Always check product labeling and follow personalized guidance from your healthcare provider.

Is L-Phenylalanine / DLPA worth taking?

L-Phenylalanine / DLPA has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. L-Phenylalanine / DLPA is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of L-Phenylalanine / DLPA?

The clinically studied dose for L-Phenylalanine / DLPA is L-phenylalanine: 500–1,500 mg/day for mood/cognitive support; DLPA: 375–2,250 mg/day for chronic pain; vitiligo: 50–100 mg/kg combined with UV therapy. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is L-Phenylalanine / DLPA used for?

L-Phenylalanine / DLPA is studied for catecholamine precursor (mood support), chronic pain (dlpa), vitiligo adjunct (with uv therapy). L-Phenylalanine converts to L-tyrosine, then to L-DOPA, then to dopamine, norepinephrine, and epinephrine. Theoretical basis for mood and cognitive support — though clinical trials in depression have been mixed and small.